- Home
- NAC vs QURE Comparison
NAC vs QURE Comparison
Compare NAC & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAC | QURE |
|---|---|---|
| Founded | 1998 | 1998 |
| Country | France | Netherlands |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | NAC | QURE |
|---|---|---|
| Price | $11.78 | $22.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $58.55 |
| AVG Volume (30 Days) | 307.3K | ★ 1.6M |
| Earning Date | 01-01-0001 | 02-26-2026 |
| Dividend Yield | ★ 4.33% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,751,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $142.93 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.32 | $7.76 |
| 52 Week High | $11.21 | $71.50 |
Technical Indicators
Market Signals| Indicator | NAC | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 41.49 | 45.35 |
| Support Level | $11.75 | $21.64 |
| Resistance Level | $11.87 | $23.34 |
| Average True Range (ATR) | 0.08 | 1.64 |
| MACD | -0.02 | 0.19 |
| Stochastic Oscillator | 7.46 | 19.88 |
Price Performance
Historical ComparisonAbout NAC Nuveen California Quality Municipal Income Fund
Nuveen California Quality Municipal Income Fund is a closed-end fixed income mutual fund that prominently invests in tax-exempt municipal bonds from California. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes. Its portfolio mainly includes investment-grade municipal securities of California. The fund targets various sectors such as healthcare, utilities, transportation, and consumer staples.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.